Tag Archive for: Partnership

Bionical Emas and Pharma Resources Announce Exclusive Global Clinical Trial Supply Partnership

/in

Strategic agreement secures access to essential oncology injectables for clinical trials as European shortages intensify LONDON, UK – 29 May 2025: Bionical Emas, a global provider of Clinical Trial Services, announces an exclusive global clinical trial supply agreement with Pharma Resources GmbH, German pharmaceutical company and marketing authorization holder, specialized in oncology. This strategic partnership […]

Read more

MinervaX and Wacker Biotech Announce Manufacturing Collaboration for Prophylactic Vaccine Targeting Group B Streptococcus

/in

MinervaX scaling up supply of novel GBS vaccine, ahead of phase III studies Wacker Biotech to manufacture active vaccine protein ingredients and prepare for commercial supply after regulatory approval Vaccine to address the unmet medical burden of GBS, both by maternal vaccination to prevent adverse pregnancy outcomes and life-threatening infections in infants and by vaccination […]

Read more

BaseLaunch announces a new partnership with AbbVie

/in

Media release Basel, Switzerland, 22.05.2024 BaseLaunch announces a new partnership with AbbVie Further strengthens BaseLaunch’s global pharma industry partnerships 24 early-stage biotech ventures have now been supported by BaseLaunch Portfolio companies have raised over US$ 600 million in equity capital BaseLaunch, the Basel-based biotech venture incubator, today announces that AbbVie has become its newest partner. […]

Read more

Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

/in

First patent application registered BRAIN Biotech relies on protein engineering expertise and bioinformatics for rational protein design Zwingenberg / Neuried (Germany), March 5, 2024 – BRAIN Biotech AG, leading provider of solutions for the biologization of industry, and AMSilk GmbH, a global leader in advanced materials made from spider silk-based proteins, announce the successful completion […]

Read more

DelSiTech and Tolmar Announce Global License and Development Agreement

/in

Tolmar secures global license to DelSiTech’s Silica Matrix technology to develop and commercialize two undisclosed drug targets DelSiTech and Tolmar to expand development of additional drug products across a range of therapeutic areas DelSiTech is eligible to receive upfront payments, development and commercial milestone payments, and royalties on licensed products Turku, Finland and Dublin, Ireland […]

Read more